Physician profile
Jerry Thomas
NPI 1821408527
$1,714.77
in general payments reported to CMS, 2019-2025
16 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.38 · 2021: $327 · 2022: $442 · 2023: $283 · 2024: $389 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $569.96 | 2021-2023 | |
| Medtronic, INC. | $324.76 | 2021-2024 | Cd Horizon Spinal System |
| Abbvie INC. | $156.18 | 2022-2025 | |
| Vertex Pharmaceuticals Incorporated | $108.19 | 2025 | |
| Medtronic USA, INC. | $97.38 | 2019 | |
| Spr Therapeutics, INC | $95.60 | 2022-2025 | Sprint Pns System |
| Novo Nordisk INC | $80.72 | 2023-2024 | Wegovy |
| Merck Sharp & Dohme LLC | $66.43 | 2024 | Dificid, Verquvo |
| Lilly USA, LLC | $53.26 | 2023-2024 | Jardiance, Emgality, Synjardy |
| Collegium Pharmaceutical, INC. | $40.72 | 2022 | |
| Azurity Pharmaceuticals, INC. | $26.30 | 2023 | Horizant |
| Seqirus USA INC | $22.71 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Janssen Pharmaceuticals, INC | $21.40 | 2023 | Xarelto |
| Dynavax Technologies Corporation | $18.88 | 2024 | Heplisav-B |
| Stryker Corporation | $18.27 | 2025 | Optablate |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $14.01 | 2024 | Mitraclip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.